-
Global Anticoagulant Reversal Drugs Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
26 May 2025 15:57 GMT
… health, and blockchain in drug supply … Pharmaceuticals LLC, AMAG Pharmaceuticals Inc, Glenmark Pharmaceuticals Inc USA, Alexion Pharmaceuticals Inc, Amphastar Pharmaceuticals Inc, Portola Pharmaceuticals … Pharmacy
- Retail Pharmacy
- Online Pharmacy
…
-
A biopharma doubles down on diversity goals through a newly created position
01 Jul 2025 13:22 GMT
… dedicated to examining how pharma executives and other leaders … medical officer. Prior to that, she had stints at AMAG Pharmaceuticals, … the full continuum of drug development, from discovery to … to best educate patients, healthcare providers and payors on …
-
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
13 Nov 2024 13:00 GMT
… has worked in the global pharmaceutical and medical technology industries for nearly … AMAG Pharmaceuticals, where he led its turnaround and strategic sale to Covis Pharma … capabilities across cancer biology and medicinal chemistry to advance its research …
-
David Arkowitz,MBA, joins Alkeus Pharmaceuticals as Chief Financial Officer
06 Nov 2024 13:18 GMT
… in the biotechnology and pharmaceuticals space, including Flexion … by Otsuka Pharmaceutical Co), Mascoma, AMAG Pharmaceuticals, and Idenix Pharmaceuticals. Within … Spring Bank Pharmaceuticals, Proteostasis Therapeutics, Aegerion Pharmaceuticals, and ImpactRx …
-
Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer
31 Oct 2024 12:30 GMT
… which was acquired by Otsuka Pharmaceutical Co. He also previously served … Officer at Mascoma, AMAG Pharmaceuticals and Idenix Pharmaceuticals and held additional leadership … breakthrough therapy designation and orphan drug designation for Stargardt disease …
-
Gynecology Collaboration and Licensing Agreement Trends Analysis Report 2025 | Access to 150 Deals Signed Since 2016 - Upfront, Milestone, Royalties by Company A-Z, Therapy Focus and Technology Type - ResearchAndMarkets.com
02 Jul 2025 14:12 GMT
… Technologies
Altavant Sciences
Amag Pharmaceuticals
American Dental Association
Amring Pharmaceuticals
AntibioTx
ApolloBio
Aptorum …
Conduit Pharmaceuticals
Consortia Health
ConTipi
Control Flo Medical
Coriell Life Sciences
Cosette Pharmaceuticals
CR Pharma …
-
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
19 Sep 2024 12:30 GMT
… record of successful drug approvals across … Pharmacovigilance, Quality, and Patient Advocacy at Ra Pharmaceuticals … companies, including Sucampo Pharmaceuticals, AMAG Pharmaceuticals, MedImmune (Biologics … . About Disc Medicine Disc Medicine (NASDAQ:IRON) …
-
KalVista Pharma Appoints Brian Piekos As New CFO
10 Sep 2024 10:56 GMT
KalVista Pharmaceuticals, Inc. (KALV) announced Tuesday that … President, CFO and Treasurer at AMAG Pharmaceuticals. He held leadership roles in … at Cubist Pharmaceuticals and began his career as a healthcare investment banker …
-
Iron Deficiency Anemia Market Size and Share to Grow by 2032, Predicts DelveInsight | Leading Companies Developing Therapies - Pharmacosmos, AMAG, Shield, Akebia, Keros, Keryx Biopharmaceuticals, Sierra Oncology LLC
26 Oct 2023 17:00 GMT
… Drugs
Competitive … Therapeutics, AMAG Pharmaceuticals, Pharmacosmos Therapeutics, Vifor Pharma, American … including AMAG Pharmaceuticals, Rockwell Medical., Keryx … Healthcare Services Healthcare Consulting Healthcare Competitive Intelligence Services Healthcare …
-
At Pfizer's once-troubled plant, AMAG loses insurance claim tied to manufacturing snafu
21 Aug 2024 18:32 GMT
… legal back-and-forth, AMAG Pharmaceuticals has lost its bid to … Insurance Company (AGLIC), denying AMAG’s claims of business losses … preterm birth drug Makena.
As a result, AMAG will not … AMAG owned the marketing rights to the controversial preterm birth drug …